Table 4.

Summary of Appendix Tables 10–17, which address two proteins at a time for the early epoch (4a) and separately for the late epoch (4b).^a

4a. early epoch

TNF-α

IL-8

ICAM-1

Proteins

W

I

S

E

W

I

S

E

W

I

S

E

IL-6R

V

V

V

V

V

V

MMP-9

V

Λ

V

Λ

V

RANTES

V

V

V

V

V

V

EPO

Λ

Λ

Λ

Λ

NT-4

V

V

V

V

BDNF

V

V

V

V

V

V

bFGF

Λ

V

V

V

V

IGF-1

V

V

V

V

V

VEGF

V

V

V

V

V

V

V

V

VEGF-R1

V

V

V

V

V

V

V

V

VEGF-R2

V

V

V

V

V

PIGF

V

V

V

V

V

V

V

Ang-1

V

V

V

V

V

V

V

V

Ang-2

4b. late epoch

TNF-α

IL-8

ICAM-1

Proteins

W

I

S

E

W

I

S

E

W

I

S

E

IL-6R

V

V

MMP-9

V

V

RANTES

V

V

V

V

EPO

V

V

V

V

V

V

NT-4

V

V

V

V

BDNF

V

V

bFGF

V

V

IGF-1

V

V

V

V

VEGF

V

V

VEGF-R1

V

V

V

Λ

V

VEGF-R2

Λ

V

PIGF

V

V

V

V

Ang-1

V

Ang-2

V

V

V

V

^aThe inflammation-related protein is identified at the top of each set of columns, and the neurotrophic proteins are identified on the left. Λ indicates increased risk of a Z-score < −1 on the executive dysfunction assessment(s) identified just below the inflammation-related protein, while V indicates decreased risk. W indicates a DAS-II Working Memory Z-score ≤ −1, I indicates a NEPSY-II Inhibition-inhibition Z- score ≤ −1, S indicates a NEPSY-II Inhibition-Switching Z- score ≤ −1, and E indicates the executive dysfunction composite defined as a Z-score ≤ −1 on all three assessments.